HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.7385
-0.0140 (-1.86%)
At close: Mar 20, 2026, 4:00 PM EDT
0.6775
-0.0610 (-8.26%)
After-hours: Mar 20, 2026, 7:59 PM EDT
HCW Biologics Employees
HCW Biologics had 36 employees as of December 31, 2024. The number of employees decreased by 9 or -20.00% compared to the previous year.
Employees
36
Change (1Y)
-9
Growth (1Y)
-20.00%
Revenue / Employee
$11,723
Profits / Employee
-$616,834
Market Cap
2.42M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 36 | -9 | -20.00% |
| Dec 31, 2023 | 45 | 1 | 2.27% |
| Dec 31, 2022 | 44 | 0 | - |
| Dec 31, 2021 | 44 | 4 | 10.00% |
| Mar 31, 2021 | 40 | - | - |
| Dec 31, 2020 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Scinai Immunotherapeutics | 31 |
| NuCana | 22 |
| Enveric Biosciences | 6 |
| Galmed Pharmaceuticals | 6 |
| Oragenics | 5 |
| Adial Pharmaceuticals | 5 |
| GRI Bio | 4 |
| XORTX Therapeutics | 3 |
HCWB News
- 3 days ago - HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic - GlobeNewsWire
- 4 days ago - HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances - GlobeNewsWire
- 18 days ago - HCW Biologics Regains Compliance with All Continued Listing Rules for Nasdaq Per Nasdaq Determination Letter - GlobeNewsWire
- 4 weeks ago - HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - GlobeNewsWire
- 5 weeks ago - HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune - GlobeNewsWire
- 4 months ago - HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease - GlobeNewsWire
- 4 months ago - HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results - GlobeNewsWire
- 4 months ago - HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting - GlobeNewsWire